Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$48,388,474
+$3,907,398 QoQ
Shares Held
376,564
+1.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
#323
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisors, LLC holds $319,084,682 across 12 Drug Manufacturers - General names. MRK ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
414,618 | $105,300,533 | |
| 2 | ABBV |
AbbVie Inc.
|
334,747 | $84,235,735 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
376,564 | $48,388,474 | |
| 4 | LLY |
ELI LILLY & Co
|
29,637 | $35,547,509 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
93,913 | $11,864,968 | |
| 6 | AMGN |
Amgen Inc
|
31,607 | $11,445,526 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
194,661 | $11,216,366 | |
| 8 | PFE |
Pfizer Inc
|
398,271 | $9,590,365 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,388,474 | 376,564 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $44,481,076 | 369,782 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $38,189,485 | 362,811 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $30,543,553 | 363,917 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $349,905 | 0 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $30,244,362 | 336,947 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $31,890,900 | 320,576 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $36,077,330 | 317,694 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $39,097,278 | 315,810 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $41,719,819 | 316,179 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $34,386,979 | 315,419 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $32,444,280 | 315,146 | Shares | Sole | 2023-10-16 | |
| 2023-03-31 | $41,714,455 | 392,090 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $41,732,511 | 376,138 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $28,140,915 | 326,764 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $28,326,610 | 310,701 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $24,845,478 | 302,809 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $22,833,585 | 297,933 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $23,364,467 | 311,070 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $22,921,852 | 294,739 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $20,956,619 | 271,846 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $19,599,025 | 239,597 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $17,352,733 | 209,195 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $12,561,104 | 162,435 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $11,633,246 | 151,199 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||